To compare the efficacy of Itrifal Muqil and Habb-E-Barg-E Neeb in internal piles

Comparative Evaluation of Itrifal Muqil and Habb-E-Barg-E Neeb in Bawaseer Ghaira (Internal Haemorrhoids)-A Randomized Clinical Trial.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081940

Enrollment

Registered

2025-03-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K648- Other hemorrhoids

Interventions

Intervention1: Habb-E-Barg-E Neeb: Barg-e-neeb,chakso,sandal surkh,Dhamasa, Barg-e-hina,Rasaut,Narkachoor,Filfil siyah,loab-e-Behi dana 500mg 2 pills thrice a day for 4 weeks Control Intervention1: It

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed case of internal hemorrhoids gradeI and II All Genders Age 18 to 60 years Patients who have agreed to sign the informed consent form and follow up the protocol

Exclusion criteria

Exclusion criteria: External pile mass Severe systemic illness, IBD, liver cirrhosis Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Improvement in the objective parameters i.e decrease in rectal mass if any and resolution of bleeding points or mucus bulge 4 weeksTimepoint: Improvement in the objective parameters i.e decrease in rectal mass if any and resolution of bleeding points or mucus bulge 4 weeks	—

Secondary

Measure	Time frame
Improvement in subjective parameters i.e resolution of per rectal bleeding, mucus discharge, defecation discomfort and itchingTimepoint: Nil	—

Countries

India

Contacts

Public ContactHafsa Naaz T A

National institute of Unani Medicine

drhafsa196@gmail.com8660739679

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026